カテゴリー： Transparency Market Research, 世界, 医療/バイオ

植込み型除細動器の世界市場2023～2031：製品別、エンドユーザー別

◆英語タイトル：Implantable Cardioverter Defibrillator Market (Product: Transvenous Implantable Cardiac Defibrillators and Subcutaneous Implantable Cardiac Defibrillators; End-user: Hospitals & Clinics, Ambulatory Surgery Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Transparency Market Researchが発行した調査報告書（TMR23JUL230）◆商品コード：TMR23JUL230
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2023年5月
◆ページ数：167
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社が発表した市場調査レポートによると、世界の植込み型除細動器市場規模は2023年36億ドルから予想期間中、年平均5.6％成長し、2031年までに58億ドルへ到達すると見込まれています。当レポートでは、植込み型除細動器の世界市場を対象に、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要洞察、製品別（経静脈的植込み型除細動器（T-ICD）、皮下植込み型除細動器（S-ICD））分析、エンドユーザー別（病院・診療所、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの内容を調査し、まとめています。なお、こちらのレポートに記載されている企業情報は、Boston Scientific Corporation、BIOTRONIK、Medtronic、LivaNova、Abbott、MicroPortなどが包含されています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・主要洞察
・世界の植込み型除細動器市場規模：製品別
- 経静脈的植込み型除細動器（T-ICD）の市場規模
- 皮下植込み型除細動器（S-ICD）の市場規模
・世界の植込み型除細動器市場規模：エンドユーザー別
- 病院・診療所における市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の植込み型除細動器市場規模：地域別
- 北米の植込み型除細動器市場規模
- ヨーロッパの植込み型除細動器市場規模
- アジア太平洋の植込み型除細動器市場規模
- 中南米の植込み型除細動器市場規模
- 中東・アフリカの植込み型除細動器市場規模
・競争状況

Implantable Cardioverter Defibrillator Market – Scope of Report
TMR’s report on the global Implantable Cardioverter Defibrillator market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Implantable Cardioverter Defibrillator market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Implantable Cardioverter Defibrillator market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Implantable Cardioverter Defibrillator market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Implantable Cardioverter Defibrillator market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Implantable Cardioverter Defibrillator market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Implantable Cardioverter Defibrillator market.

The report delves into the competitive landscape of the global Implantable Cardioverter Defibrillator market. Key players operating in the global Implantable Cardioverter Defibrillator market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Implantable Cardioverter Defibrillator market profiled in this report.

Key Questions Answered in Global Implantable Cardioverter Defibrillator Market Report
• What is the sales/revenue generated by Implantable Cardioverter Defibrillator across all regions during the forecast period?
• What are the opportunities in the global Implantable Cardioverter Defibrillator market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Implantable Cardioverter Defibrillator Market – Research Objectives and Research Approach
The comprehensive report on the global Implantable Cardioverter Defibrillator market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Implantable Cardioverter Defibrillator market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Implantable Cardioverter Defibrillator market.

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Implantable Cardioverter Defibrillator Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Implantable Cardioverter Defibrillator Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
    5.1. Disease Prevalence & Incidence Rate globally with key countries
    5.2. Regulatory Scenario by Region/globally
    5.3. Key Product/Brand Analysis
    5.4. COVID-19 Pandemics Impact on Industry
6. Global Implantable Cardioverter Defibrillator Market Analysis and Forecast, by Product
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product, 2017-2031
        6.3.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
            6.3.1.1. Cardiac Resynchronization Therapy (CRT)
            6.3.1.2. Dual Chamber ICDs
            6.3.1.3. Single Chamber ICDs
        6.3.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
    6.4. Market Attractiveness Analysis, by Product
7. Global Implantable Cardioverter Defibrillator Market Analysis and Forecast, by End-user
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by End-user, 2017-2031
        7.3.1. Hospitals & Clinics
        7.3.2. Ambulatory Surgery Centers
        7.3.3. Others
    7.4. Market Attractiveness Analysis, by End-user
8. Global Implantable Cardioverter Defibrillator Market Analysis and Forecast, by Region
    8.1. Key Findings
    8.2. Market Value Forecast, by Region
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Market Attractiveness Analysis, by Region
9. North America Implantable Cardioverter Defibrillator Market Analysis and Forecast
    9.1. Introduction
        9.1.1. Key Findings
    9.2. Market Value Forecast, by Product, 2017-2031
        9.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
            9.2.1.1. Cardiac Resynchronization Therapy (CRT)
            9.2.1.2. Dual Chamber ICDs
            9.2.1.3. Single Chamber ICDs
        9.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
    9.3. Market Value Forecast, by End-user, 2017-2031
        9.3.1. Hospitals & Clinics
        9.3.2. Ambulatory Surgery Centers
        9.3.3. Others
    9.4. Market Value Forecast, by Country, 2017-2031
        9.4.1. U.S.
        9.4.2. Canada
    9.5. Market Attractiveness Analysis
        9.5.1. By Product
        9.5.2. By End-user
        9.5.3. By Country
10. Europe Implantable Cardioverter Defibrillator Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product, 2017-2031
        10.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
            10.2.1.1. Cardiac Resynchronization Therapy (CRT)
            10.2.1.2. Dual Chamber ICDs
            10.2.1.3. Single Chamber ICDs
        10.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
    10.3. Market Value Forecast, by End-user, 2017-2031
        10.3.1. Hospitals & Clinics
        10.3.2. Ambulatory Surgery Centers
        10.3.3. Others
    10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
        10.4.1. Germany
        10.4.2. U.K.
        10.4.3. France
        10.4.4. Spain
        10.4.5. Italy
        10.4.6. Rest of Europe
    10.5. Market Attractiveness Analysis
        10.5.1. By Product
        10.5.2. By End-user
        10.5.3. By Country/Sub-region
11. Asia Pacific Implantable Cardioverter Defibrillator Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product, 2017-2031
        11.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
            11.2.1.1. Cardiac Resynchronization Therapy (CRT)
            11.2.1.2. Dual Chamber ICDs
            11.2.1.3. Single Chamber ICDs
        11.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
    11.3. Market Value Forecast, by End-user, 2017-2031
        11.3.1. Hospitals & Clinics
        11.3.2. Ambulatory Surgery Centers
        11.3.3. Others
    11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
        11.4.1. China
        11.4.2. Japan
        11.4.3. India
        11.4.4. Australia & New Zealand
        11.4.5. Rest of Asia Pacific
    11.5. Market Attractiveness Analysis
        11.5.1. By Product
        11.5.2. By End-user
        11.5.3. By Country/Sub-region
12. Latin America Implantable Cardioverter Defibrillator Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product, 2017-2031
        12.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
            12.2.1.1. Cardiac Resynchronization Therapy (CRT)
            12.2.1.2. Dual Chamber ICDs
            12.2.1.3. Single Chamber ICDs
        12.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
    12.3. Market Value Forecast, by End-user, 2017-2031
        12.3.1. Hospitals & Clinics
        12.3.2. Ambulatory Surgery Centers
        12.3.3. Others
    12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
        12.4.1. Brazil
        12.4.2. Mexico
        12.4.3. Rest of Latin America
    12.5. Market Attractiveness Analysis
        12.5.1. By Product
        12.5.2. By End-user
        12.5.3. By Country/Sub-region
13. Middle East & Africa Implantable Cardioverter Defibrillator Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product, 2017-2031
        13.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
            13.2.1.1. Cardiac Resynchronization Therapy (CRT)
            13.2.1.2. Dual Chamber ICDs
            13.2.1.3. Single Chamber ICDs
        13.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
    13.3. Market Value Forecast, by End-user, 2017-2031
        13.3.1. Hospitals & Clinics
        13.3.2. Ambulatory Surgery Centers
        13.3.3. Others
    13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
        13.4.1. GCC Countries
        13.4.2. South Africa
        13.4.3. Rest of Middle East & Africa
    13.5. Market Attractiveness Analysis
        13.5.1. By Product
        13.5.2. By End-user
        13.5.3. By Country/Sub-region
14. Competition Landscape
    14.1. Market Player – Competition Matrix (by tier and size of companies)
    14.2. Market Share Analysis, by Company (2022)
    14.3. Company Profiles
        14.3.1. Boston Scientific Corporation
            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.1.2. Product Portfolio
            14.3.1.3. Financial Overview
            14.3.1.4. SWOT Analysis
            14.3.1.5. Strategic Overview
        14.3.2. BIOTRONIK
            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.2.2. Product Portfolio
            14.3.2.3. Financial Overview
            14.3.2.4. SWOT Analysis
            14.3.2.5. Strategic Overview
        14.3.3. Medtronic
            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.3.2. Product Portfolio
            14.3.3.3. Financial Overview
            14.3.3.4. SWOT Analysis
            14.3.3.5. Strategic Overview
        14.3.4. LivaNova
            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.4.2. Product Portfolio
            14.3.4.3. Financial Overview
            14.3.4.4. SWOT Analysis
            14.3.4.5. Strategic Overview
        14.3.5. Abbott
            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.5.2. Product Portfolio
            14.3.5.3. Financial Overview
            14.3.5.4. SWOT Analysis
            14.3.5.5. Strategic Overview
        14.3.6. MicroPort
            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.6.2. Product Portfolio
            14.3.6.3. Financial Overview
            14.3.6.4. SWOT Analysis
            14.3.6.5. Strategic Overview

List of Tables

Table 01: Global Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031

Table 02: Global Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031

Table 03: Global Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Region, 2017-2031

Table 04: North America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031

Table 05: North America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031

Table 06: North America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country, 2017-2031

Table 07: Europe Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031

Table 08: Europe Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031

Table 09: Europe Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031

Table 10: Asia Pacific Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031

Table 11: Asia Pacific Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031

Table 12: Asia Pacific Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031

Table 13: Latin America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031

Table 14: Latin America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031

Table 15: Latin America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031

Table 16: Middle East & Africa Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031

Table 17: Middle East & Africa Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031

Table 18: Middle East & Africa Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 植込み型除細動器の世界市場2023～2031：製品別、エンドユーザー別(Implantable Cardioverter Defibrillator Market (Product: Transvenous Implantable Cardiac Defibrillators and Subcutaneous Implantable Cardiac Defibrillators; End-user: Hospitals & Clinics, Ambulatory Surgery Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 植込み型除細動器の世界市場2023-2030：市場規模、シェア、動向分析
  • 心臓埋め込み型電子機器の世界市場2022～2031：製品別
  • スマート医療用インプラントの世界市場2023～2031：用途別、エンドユーザー別、地域別
  • 吸収可能型抗菌エンベロープの世界市場2022～2031：用途別
  • 植え込み型除細動器の世界市場2024-2030：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆